Innate Immune Status of Glia Modulates Prion Propagation in Early Stage of Infection
Cells · 2023
DOI: 10.3390/cells12141878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Sang-Gyun Kang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, AB T6G 2M8, Canada. Hauptthemen laut MEDLINE: Prions, Prion Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSERC Discovery, Alberta Prion Research Institute, Genome Canada.
Abstract (Originalsprache)
Prion diseases are progressive neurodegenerative disorders affecting humans and various mammals. The prominent neuropathological change in prion-affected brains is neuroinflammation, histopathologically characterized by reactive gliosis surrounding prion deposition. The cause and effect of these cellular responses are still unclear. Here we investigate the impact of innate immune responses on prion replication using in vitro cell culture models. Hamster-adapted transmissible mink encephalopathy prions, hyper (HY) and drowsy (DY) strains, were assayed for accumulation of pathogenic prion protein (PrPSc) in primary glial cultures derived from 8-day-old hamster pups. The kinetics of PrPSc accumulation largely depended on prion strain and brain regions from where glial cells originated. Glial cells derived from the cerebellum were susceptible to HY, but resistant to DY strain as determined by western blot analysis, immunocytochemistry, and animal bioassay. Glial cells from the cerebral cortex were, however, refractory to both strains. PrPSc accumulation was affected by innate immune modulators. Priming glial cells with lipopolysaccharide decreased prion replication, whereas pre-treatment with dexamethasone, inhibiting innate immunity, increased susceptibility to DY infection. Our results suggest that neuroinflammation resulting from prion infection is a response to resolve and/or prevent prion propagation in the brain. It implies a therapeutic potential of innate immune modulation in the early stages of prion disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, AB T6G 2M8, Canada.
- Department of Medicine, University of Alberta, Edmonton, AB T6G 2R7, Canada.
- Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada.
- Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, AB T6G 1C9, Canada.
ORCID-Profile: Sang-Gyun Kang
Förderung
- NSERC Discovery
- Alberta Prion Research Institute
- Genome Canada
Zitieren
APA
Kang, S. G., Kim, C., Aiken, J., & McKenzie, D. (2023). Innate Immune Status of Glia Modulates Prion Propagation in Early Stage of Infection. Cells. https://doi.org/10.3390/cells12141878
Vancouver
Kang SG, Kim C, Aiken J, McKenzie D. Innate Immune Status of Glia Modulates Prion Propagation in Early Stage of Infection. Cells. 2023. doi:10.3390/cells12141878
BibTeX
@article{Kang2023,
author = {Kang, Sang-Gyun and Kim, Chiye and Aiken, Judd and McKenzie, Debbie},
title = {Innate Immune Status of Glia Modulates Prion Propagation in Early Stage of Infection},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12141878}
}
EUVIMED